These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12079602)

  • 1. Exploring the complexity of compliance in schizophrenia.
    Pinikahana J; Happell B; Taylor M; Keks NA
    Issues Ment Health Nurs; 2002; 23(5):513-28. PubMed ID: 12079602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of partial compliance.
    Marder SR
    J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which factors modify drug-compliance?].
    Albus M; Burkes S; Scherer J
    Psychiatr Prax; 1995 Nov; 22(6):228-30. PubMed ID: 8570752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lack of insight in schizophrenia: a review].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Oct; 34(5):511-6. PubMed ID: 19068341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing compliance in schizophrenia patients.
    Fleischhacker WW; Oehl MA; Hummer M
    J Clin Psychiatry; 2003; 64 Suppl 16():10-3. PubMed ID: 14680413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differentiation between 'lack of insight' and 'dysfunctional health beliefs' in schizophrenia.
    Linden M; Godemann F
    Psychopathology; 2007; 40(4):236-41. PubMed ID: 17396050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
    Tsang HW; Fung KM; Corrigan PW
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compliance in the treatment of schizophrenia -- results of an expert survey in Saxony and Saxony-Anhalt].
    Giessler A; Born A; Helm H; Puschner B; Becker T
    Psychiatr Prax; 2005 Oct; 32(7):349-57. PubMed ID: 16220419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].
    Hartung HD
    Fortschr Med; 1998 Jan; 116(3):28-30. PubMed ID: 9522542
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors important for compliance among Croatian patients suffering from schizophrenia--how to improve psychiatric services in Croatia?
    Martić-Biocina S; Barić V
    Psychiatr Danub; 2005 Jun; 17(1-2):36-41. PubMed ID: 16395842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.